The more you move, the better it works
We track your progress closely at our Minnetonka center to ensure optimal outcomes
Glucagon-like peptide-1 receptor (GLP-1R) agonists are a group of drugs that targets incretin hormone action, and its receptors are widely distributed in nerves, islets, heart, lung, skin, and other organs
CJC-1295 + Ipamorelin remains an investigational research product intended exclusively for laboratory and scientific research purposes and is not approved by the U.S
Risks, Side Effects, and What Honest Prescribing Looks Like Common and Expected Side Effects Nausea, vomiting, diarrhea, constipation most common, especially during dose titration Gastric emptying delay with gastroparesis-like symptoms clinically significant for patients on structured meal plans Fatigue, particularly early in treatment Hair thinning with higher doses or prolonged caloric restriction Dehydration secondary to gastrointestinal effects Serious but Less Common Risks Acute pancreatitis requires immediate cessation and medical management Gallbladder disease increased incidence with rapid weight loss Thyroid C-cell tumor risk observed in animal studies
Maintenance After Discontinuation Neither peptide is intended to be a short-term intervention